The results of the prognostic model on HCC prognosis and chemosensitivity as constructed using BACE1-AS and NRP1 further confirm the close relationship between BACE1-AS and tumor immunity in tumor progression. This evidence concerns the gene BACE1 and hepatocellular carcinoma.